Tech Center 1600 • Art Units: 1615
This examiner grants 45% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18375162 | ANHYDROUS SODIUM THIOSULFATE AND FORMULATIONS THEREOF | Non-Final OA | Fennec Pharmaceuticals Inc. |
| 17698906 | COMPOSITIONS FOR DELIVERY OF DRUG COMBINATIONS TO TREAT LUNG DISEASE | Non-Final OA | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM |
| 17815485 | GRAPHENE BIOSCAFFOLDS AND THEIR USE IN CELLULAR THERAPY | Non-Final OA | The Board of Trustees of the Leland Stanford Junior University |
| 18508058 | BIOMIMETIC LIPOSOMES AND METHODS OF MAKING AND USING THE SAME | Non-Final OA | Worcester Polytechnic Institute |
| 17256944 | SUBSTITUTED THIOPHENECARBOXAMIDES AND ANALOGUES AS ANTIBACTERIALS AGENTS | Non-Final OA | Bayer Aktiengesellschaft |
| 17339652 | TREATMENT OF CYSTINOSIS | Non-Final OA | Nacuity Pharmaceuticals, Inc. |
| 17156560 | PRODRUG FOR THE TREATMENT OF DISEASE AND INJURY OF OXIDATIVE STRESS | Non-Final OA | Nacuity Pharmaceuticals, Inc. |
| 17255799 | SEED TREATMENT METHOD | Final Rejection | Bayer CropScience LP |
| 18282554 | FORMULATIONS COMPRISING A THERAPEUTIC PROTEIN AND AT LEAST ONE STABILIZER | Non-Final OA | UCB BIOPHARMA SRL |
| 17955609 | Implantable Medical Device for the Delivery of a Nucleic Acid | Non-Final OA | Celanese EVA Performance Polymers LLC |
| 17705441 | Implantable Medical Device for the Delivery of Nucleic Acid-Encapsulated Particles | Non-Final OA | Celanese EVA Performance Polymers LLC |
| 18282380 | VITAMIN D FORMULATIONS | Non-Final OA | SOLMIC BIOTECH GMBH |
| 18208177 | NOVEL DISINTEGRATION ORAL FILM FORMULATION WITH A CONTROLLED OR SUSTAINED ACTIVE RELEASE | Final Rejection | INTELGENX CORP. |
| 17802078 | PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION | Final Rejection | HK INNO. N CORPORATION |
| 18259552 | WATER-SOLUBLE CANNABINOID FORMULATION AND PREPARATION METHOD THEREFOR | Non-Final OA | HANYI BIOTECHNOLOGY (BEIJING) CO., LTD |
| 17926433 | CANNABIDIOL AND ACTIVE DELIVERY SYSTEMS | Final Rejection | ELEMENTIS SPECIALTIES, INC. |
| 18004601 | ANTI-CANCER ACTIVITY OF PERBORATE SALTS | Non-Final OA | ALIYA PHARMACEUTICALS INC. |
| 18011668 | PLATELET MEMBRANE COATED NANOPARTICLES AND USES THEREOF | Final Rejection | CELLO THERAPEUTICS, INC. |
| 17998524 | SOLID ORAL COMPOSITIONS COMPRISING COMPOSITE MONOLITHIC MATRICES FOR CHRONOTROPIC ADMINISTRATION OF ACTIVE INGREDIENTS IN THE GASTROINTESTINAL TRACT | Non-Final OA | MOGON PHARMACEUTICALS SAGL |
| 17910239 | A NANOPARTICLE FOR USE IN THE TREATMENT OF AN OCULAR DISEASE | Non-Final OA | UNIVERSITÄT REGENSBURG |
| 17697779 | IMMEDIATE POST-PROCEDURE RECOVERY FORMULATION AND METHOD | Non-Final OA | JAMRM, LLC |
| 17620167 | BIODEGRADABLE DRUG-ELUTING EMBOLIC PARTICLES FOR DELIVERY OF THERAPEUTIC AGENTS | Non-Final OA | Jeffrey WANG |
| 17347148 | HYDROGEL COMPOSITIONS ENCAPSULATING SOLID PARTICLES | Non-Final OA | GALDERMA HOLDING SA |
| 17284650 | SUSPENSION FORMULATIONS OF HIGH LOAD DISPERSIONS | Final Rejection | Austin Research Labs Corp. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy